ARCHIVES

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

This article is from The Cancer Letter archive.

Vol. 28 No. 31 | August 2, 2002

Download PDF Visit The Full Archive

Related Articles

Clinton Administration Issues Research Misconduct Policy.

December 8, 2000

HEW Says Patent Delays Temporary

August 25, 1978

Obit: J. Gale Katterhagen, NCAB’s First Community Physician.

May 4, 2001

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Letters: Broder Response To Waxman Called Political Back-Pedaling

February 11, 1994

Grassley Pledges More Congressional Oversight of CME.

March 14, 2008